Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 11277642

Carboplatin alone vs carboplatin plus epidoxorubicin as second-line therapy for cisplatin- or carboplatin-sensitive ovarian cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Gynecol Oncol
Publication date
2001 Apr
First author
Bolis G

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Gynecol Oncol. 2001 Apr;81(1):1-2. doi: 10.1006/gyno.2001.6162.
    note
    Source null
    related pmid
    11277641
    relationship
    Comment in

Authors and identifiers

  1. name
    Bolis G
    type
    Author
  2. name
    Scarfone G
    type
    Author
  3. name
    Giardina G
    type
    Author
  4. name
    Villa A
    type
    Author
  5. name
    Mangili G
    type
    Author
  6. name
    Melpignano M
    type
    Author
  7. name
    Presti M
    type
    Author
  8. name
    Tateo S
    type
    Author
  9. name
    Franchi M
    type
    Author
  10. name
    Parazzini F
    type
    Author
  11. name
    Associazione per la Ricerca in Ginecologia Oncologia (ARGO 96) Study Group
    type
    CollectiveName
Complete bibliographic record and source provenance
authors
  1. name
    Bolis G
    type
    Author
  2. name
    Scarfone G
    type
    Author
  3. name
    Giardina G
    type
    Author
  4. name
    Villa A
    type
    Author
  5. name
    Mangili G
    type
    Author
  6. name
    Melpignano M
    type
    Author
  7. name
    Presti M
    type
    Author
  8. name
    Tateo S
    type
    Author
  9. name
    Franchi M
    type
    Author
  10. name
    Parazzini F
    type
    Author
  11. name
    Associazione per la Ricerca in Ginecologia Oncologia (ARGO 96) Study Group
    type
    CollectiveName
bibliography ids
  1. nci-bib-42b96679452d42c1b456f94d
book metadata
content sha256
7fba40db4090dfef18a1c957e0d00b41c81447bfe13bfac0b6c7d6666364d580
document type
citation
dois
  1. 10.1006/gyno.2001.6151
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:11277642
immutable id
pubmed:11277642@7fba40db4090dfef18a1c957e0d00b41c81447bfe13bfac0b6c7d6666364d580
journal
abbreviation
Gynecol Oncol
issn electronic
Source null
issn print
0090-8258
issue
1
name
Gynecologic oncology
nlm unique id
0365304
pages
3-9
volume
81
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Gynecol Oncol. 2001 Apr;81(1):1-2. doi: 10.1006/gyno.2001.6162.
    note
    Source null
    related pmid
    11277641
    relationship
    Comment in
outcomes validated
false
pmid
11277642
provenance
batch id
30d2cd7affbbb92b6784
provider
NCBI PubMed ESummary
record sha256
c30963944d866885b8cb7f35435c6920c2b6d1c3554dea747d2cbfd2e29690ac
response sha256
ae7ed930f8b43c9e34eeae02f278f33f49c15777b81f742392c120eb64949120
retrieved at
2026-09-09T23:45:39.779418+00:00
publication date
display
2001 Apr
precision
month
year
2001
publication types
  1. Clinical Trial
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/11277642/
title
Carboplatin alone vs carboplatin plus epidoxorubicin as second-line therapy for cisplatin- or carboplatin-sensitive ovarian cancer.

Preserved source evidence · Not medical advice